| Ireland: Master of Science in Pharmaceutical Medicine (webbased) - Hibernia College - Dublin |
1. Title of the Course: 2. Main University organising the Course: 3. Address of Secretariat of the Course: 4. Year of Foundation of the Course: 2005 5. Seminars/Modules: Module 1 Leadership & Authority Of these 10 modules 7 are taught on-line, 2 are taught on-site and 1 consists of working on a research project and the writing of a dissertation.
The on-site modules are:
Each on-site module takes 36 hours teaching plus an assessment. The on-site modules are not compulsory. They can be learned on-line by those students who cannot attend the courses in Harvard and/or Dublin. Frequency of seminars/modules: 2 modules/semester The seminars/modules are spread over 2 years The full course contains 432 hours of teaching distributed as follows: Seminars (didactic lectures): 3 x 12 x 7 = 252 hrs The programme covers all items mentioned in the IFAPP Syllabus and the syllabus of the Faculty of Pharmaceutical Medicine in London. 6. Hours of teaching: Clinical Research: 88 hrs 7. Teachers: Total number of teachers participating in the programme: 46 Of whom: * Private pharmaceutical consultants or small consultancy companies. 8. Course material The course material consists of paper documents as well as of electronic media. The course material is prepared by each teacher. 9. Students Average number of students registering each year: To the full course: 40 Requirements to register for the course and the examinations Applicants should also be working in the pharmaceutical industry or a CRO. 10. Examinations: Each module is assessed by a combination of continuous assessment (usually an essay or case study) and an examination at the end of the module. The marks awarded for continuous assessment and examination are usually in the ratio of 40:60. The final course award is based on the cumulative grades from all of the individual course modules. Students must pass each module. The examinations are only written. The written examination includes Multiple Choice Questions (MCQs). at each session. The number of questions varies since some module examinations consist of a number of assessment strategies of which MCQs represent only one tool. The number of correct choices varies according to the assessment strategy of the module. Short questions or short dissertations are also employed in the assessment. 11. Recognition: The course is recognised by HETAC (see above) and it is planned to have it recognised also by the National Health Authorities, the National Academy of Medicine, the Faculty of Pharmaceutical Medicine, the Regulatory Authorities and the Employers. 12. Fees: Fee for the attendance to: No fee is requested for awarding the diploma. SUMMARY The syllabus for this course incorporates all of the recommendations of the Council for Education in Pharmaceutical Medicine (CEPM) of the International Federation of Associations of Pharmaceutical Physicians (IFAPP). The syllabus also covers the content required by the Faculty of Pharmaceutical Medicine, Royal College of Physicians, UK. In addition to the core content required by these bodies, the Hibernia course offers education in a broader area of expertise, including leadership and negotiation, the fundamentals of IT and technological advances in the pharmaceutical industry, eMedicine, business ethics, intellectual property protection regulations, health economics and finance. There is also a research project and dissertation aimed at answering mission critical issues within the students' individual areas of employment. This research project provides students with an opportunity to synthesise the course as a whole in to a single piece of high quality research. The course is taught by academics from some of the world's leading Universities and from specialists from within the pharmaceutical industry from companies such as Pfizer, AstraZenaca and SmithKlineBeecham. The course is open to both physicians and non-medical specialists who are employed in the pharmaceutical industry in areas such as Pre-Clinical Pharmacology, Clinical Monitoring, Data Management, Drug Safety and Clinical Project Management. The course provides the opportunity for career advancement and cross-specialisation in the area of Clinical Development. |
|
|